0001209191-23-014626.txt : 20230302 0001209191-23-014626.hdr.sgml : 20230302 20230302161317 ACCESSION NUMBER: 0001209191-23-014626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oakes Gregory CENTRAL INDEX KEY: 0001809796 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39971 FILM NUMBER: 23699073 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Landos Biopharma, Inc. CENTRAL INDEX KEY: 0001785345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 815085535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 KRAFT DRIVE, SUITE 216 CITY: BLACKSBURG STATE: VA ZIP: 24060 BUSINESS PHONE: 540-818-2844 MAIL ADDRESS: STREET 1: 1800 KRAFT DRIVE, SUITE 216 CITY: BLACKSBURG STATE: VA ZIP: 24060 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-28 0 0001785345 Landos Biopharma, Inc. LABP 0001809796 Oakes Gregory C/O LANDOS BIOPHARMA, INC. PO BOX 11239 BLACKSBURG VA 24062 1 1 0 0 Chief Executive Officer Employee Stock Option (right to buy) 0.37 2023-02-28 4 A 0 475300 0.00 A 2033-02-27 Common Stock 475300 475300 D 1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. /s/ Gregory Oakes 2023-03-02